78/100B107.460
USD
1.63
(1.54%)
Market Open
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 0.66Revenue estimate 1.71B
Q4 FY2026 · Earnings report
EPS estimate 0.66Revenue estimate 1.71B
Edwards Lifesciences cash on hand 1999–2026What is a balance sheet? The balance sheet lists what a company owns (assets), what it owes (liabilities) and what is left for its shareholders (equity) on one date.
Edwards Lifesciences had 4.64B USD in cash and short-term investments on 30 September 2026, up 20.9% on a year before. At the end of fiscal year 2025 it had 4.23B USD.
Last updated 10 Nov 2026 · Next report 9 Feb 2027
Cash on hand
Growth
| Fiscal year | Period ending | Cash on hand | Growth | Total debt | Net cash |
|---|---|---|---|---|---|
| Latest quarter | 30 Sept 2026 | 4.64B | +20.89% | 704.50M | 3.94B |
| FY2025 | 31 Dec 2025 | 4.23B | +6.31% | 705.40M | 3.52B |
| FY2024 | 31 Dec 2024 | 3.98B | +143.50% | 700.00M | 3.28B |
| FY2023 | 31 Dec 2023 | 1.63B | +34.35% | 685.10M | 947.70M |
| FY2022 | 31 Dec 2022 | 1.22B | -17.15% | 691.30M | 524.00M |
| FY2021 | 31 Dec 2021 | 1.47B | +4.58% | 690.30M | 776.50M |
| FY2020 | 31 Dec 2020 | 1.40B | -7.54% | 694.90M | 707.70M |
| FY2019 | 31 Dec 2019 | 1.52B | +58.59% | 678.80M | 838.10M |
| FY2018 | 31 Dec 2018 | 956.50M | -28.49% | 593.80M | 362.70M |
| FY2017 | 31 Dec 2017 | 1.34B | +5.22% | 1.04B | 301.10M |
| FY2016 | 31 Dec 2016 | 1.27B | +3.79% | 822.30M | 448.80M |
| FY2015 | 31 Dec 2015 | 1.22B | -14.88% | 596.90M | 627.80M |
| FY2014 | 31 Dec 2014 | 1.44B | +53.57% | 598.10M | 840.70M |
| FY2013 | 31 Dec 2013 | 936.90M | +79.69% | 593.10M | 343.80M |
| FY2012 | 31 Dec 2012 | 521.40M | +15.74% | 189.30M | 332.10M |
| FY2011 | 31 Dec 2011 | 450.50M | +13.73% | 150.40M | 300.10M |
| FY2010 | 31 Dec 2010 | 396.10M | +18.56% | 41.80M | 354.30M |
| FY2009 | 31 Dec 2009 | 334.10M | +47.31% | 90.30M | 243.80M |
| FY2008 | 31 Dec 2008 | 226.80M | +18.62% | 175.50M | 51.30M |
| FY2007 | 31 Dec 2007 | 191.20M | +4.60% | 211.70M | -20.50M |
| FY2006 | 31 Dec 2006 | 182.80M | +2.35% | 235.90M | -53.10M |
| FY2005 | 31 Dec 2005 | 178.60M | +265.24% | 316.10M | -137.50M |
| FY2004 | 31 Dec 2004 | 48.90M | -19.97% | 267.10M | -218.20M |
| FY2003 | 31 Dec 2003 | 61.10M | +78.65% | 255.80M | -194.70M |
| FY2002 | 31 Dec 2002 | 34.20M | -28.75% | 245.50M | -211.30M |
| FY2001 | 31 Dec 2001 | 48.00M | +71.43% | 310.90M | -262.90M |
| FY2000 | 31 Dec 2000 | 28.00M | — | 428.00M | -400.00M |
| FY1999 | 31 Dec 1999 | 0.00 | — | 0.00 | 0.00 |
| Quarter | Period ending | Cash on hand | Growth on a year before | Total debt | Net cash |
|---|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 4.64B | +20.89% | 704.50M | 3.94B |
| Q2 FY2026 | 30 Jun 2026 | 4.25B | +4.69% | 704.40M | 3.55B |
| Q1 FY2026 | 31 Mar 2026 | 3.67B | -5.80% | 702.90M | 2.97B |
| Q4 FY2025 | 31 Dec 2025 | 4.23B | +6.31% | 705.40M | 3.52B |
| Q3 FY2025 | 30 Sept 2025 | 3.84B | -13.59% | 700.30M | 3.14B |
| Q2 FY2025 | 30 Jun 2025 | 4.06B | +104.15% | 702.60M | 3.36B |
| Q1 FY2025 | 31 Mar 2025 | 3.90B | +129.65% | 699.40M | 3.20B |
| Q4 FY2024 | 31 Dec 2024 | 3.98B | +143.50% | 700.00M | 3.28B |
| Q3 FY2024 | 30 Sept 2024 | 4.45B | +138.54% | 706.70M | 3.74B |
| Q2 FY2024 | 30 Jun 2024 | 1.99B | +31.84% | 693.00M | 1.30B |
| Q1 FY2024 | 31 Mar 2024 | 1.70B | +35.35% | 699.20M | 998.40M |
| Q4 FY2023 | 31 Dec 2023 | 1.63B | +34.35% | 685.10M | 947.70M |
| Q3 FY2023 | 30 Sept 2023 | 1.86B | +7.20% | 691.10M | 1.17B |
| Q2 FY2023 | 30 Jun 2023 | 1.51B | -0.43% | 684.50M | 824.80M |
| Q1 FY2023 | 31 Mar 2023 | 1.25B | -16.16% | 687.80M | 566.40M |
| Q4 FY2022 | 31 Dec 2022 | 1.22B | -17.15% | 691.30M | 524.00M |
| Q3 FY2022 | 30 Sept 2022 | 1.74B | -3.12% | 686.80M | 1.05B |
| Q2 FY2022 | 30 Jun 2022 | 1.52B | -2.91% | 682.80M | 833.00M |
| Q1 FY2022 | 31 Mar 2022 | 1.50B | +12.42% | 688.20M | 807.70M |
| Q4 FY2021 | 31 Dec 2021 | 1.47B | +4.58% | 690.30M | 776.50M |
| Q3 FY2021 | 30 Sept 2021 | 1.79B | +38.55% | 684.10M | 1.11B |
| Q2 FY2021 | 30 Jun 2021 | 1.56B | +34.15% | 684.20M | 877.00M |
| Q1 FY2021 | 31 Mar 2021 | 1.33B | +29.05% | 688.80M | 641.80M |
| Q4 FY2020 | 31 Dec 2020 | 1.40B | -7.54% | 694.90M | 707.70M |
| Q3 FY2020 | 30 Sept 2020 | 1.30B | -4.54% | 690.10M | 605.20M |
| Q2 FY2020 | 30 Jun 2020 | 1.16B | +24.56% | 684.50M | 479.30M |
| Q1 FY2020 | 31 Mar 2020 | 1.03B | +7.07% | 675.20M | 355.90M |
| Q4 FY2019 | 31 Dec 2019 | 1.52B | +58.59% | 678.80M | 838.10M |
| Q3 FY2019 | 30 Sept 2019 | 1.36B | -14.97% | 670.70M | 686.20M |
| Q2 FY2019 | 30 Jun 2019 | 934.30M | -33.30% | 668.30M | 266.00M |
| Q1 FY2019 | 31 Mar 2019 | 963.00M | -35.77% | 666.20M | 296.80M |
| Q4 FY2018 | 31 Dec 2018 | 956.50M | -28.49% | 593.80M | 362.70M |
| Q3 FY2018 | 30 Sept 2018 | 1.60B | +13.75% | 1.19B | 402.20M |
| Q2 FY2018 | 30 Jun 2018 | 1.40B | +23.77% | 1.19B | 207.70M |
| Q1 FY2018 | 31 Mar 2018 | 1.50B | +63.29% | 1.05B | 444.70M |
| Q4 FY2017 | 31 Dec 2017 | 1.34B | +5.22% | 1.04B | 301.10M |
| Q3 FY2017 | 30 Sept 2017 | 1.40B | +16.87% | 1.03B | 368.80M |
| Q2 FY2017 | 30 Jun 2017 | 1.13B | +6.75% | 1.02B | 115.00M |
| Q1 FY2017 | 31 Mar 2017 | 918.20M | -3.53% | 847.90M | 70.30M |
| Q4 FY2016 | 31 Dec 2016 | 1.27B | +3.79% | 822.30M | 448.80M |
| Q3 FY2016 | 30 Sept 2016 | 1.20B | -4.01% | 600.60M | 599.70M |
| Q2 FY2016 | 30 Jun 2016 | 1.06B | -24.76% | 602.50M | 457.70M |
| Q1 FY2016 | 31 Mar 2016 | 951.80M | -30.57% | 602.20M | 349.60M |
| Q4 FY2015 | 31 Dec 2015 | 1.22B | -14.88% | 596.90M | 627.80M |
| Q3 FY2015 | 30 Sept 2015 | 1.25B | -17.46% | 604.90M | 645.60M |
| Q2 FY2015 | 30 Jun 2015 | 1.41B | -5.06% | 600.30M | 808.70M |
| Q1 FY2015 | 31 Mar 2015 | 1.37B | +64.84% | 602.70M | 768.10M |
| Q4 FY2014 | 31 Dec 2014 | 1.44B | +53.57% | 598.10M | 840.70M |
| Q3 FY2014 | 30 Sept 2014 | 1.52B | +99.99% | 610.00M | 905.10M |
| Q2 FY2014 | 30 Jun 2014 | 1.48B | +158.10% | 598.00M | 886.10M |
| Q1 FY2014 | 31 Mar 2014 | 831.60M | +49.06% | 725.40M | 106.20M |
| Q4 FY2013 | 31 Dec 2013 | 936.90M | +79.69% | 593.10M | 343.80M |
| Q3 FY2013 | 30 Sept 2013 | 757.60M | +21.70% | 532.10M | 225.50M |
| Q2 FY2013 | 30 Jun 2013 | 575.00M | +13.64% | 227.30M | 347.70M |
| Q1 FY2013 | 31 Mar 2013 | 557.90M | +36.24% | 192.70M | 365.20M |
| Q4 FY2012 | 31 Dec 2012 | 521.40M | +15.74% | 189.30M | 332.10M |
| Q3 FY2012 | 30 Sept 2012 | 622.50M | +38.00% | 175.40M | 447.10M |
| Q2 FY2012 | 30 Jun 2012 | 506.00M | +8.07% | 185.10M | 320.90M |
| Q1 FY2012 | 31 Mar 2012 | 409.50M | -5.60% | 179.40M | 230.10M |
| Q4 FY2011 | 31 Dec 2011 | 450.50M | +13.73% | 150.40M | 300.10M |
| Q3 FY2011 | 30 Sept 2011 | 451.10M | +24.96% | 175.00M | 276.10M |
| Q2 FY2011 | 30 Jun 2011 | 468.20M | +46.18% | 174.80M | 293.40M |
| Q1 FY2011 | 31 Mar 2011 | 433.80M | +35.06% | 149.50M | 284.30M |
| Q4 FY2010 | 31 Dec 2010 | 396.10M | +18.56% | 41.80M | 354.30M |
| Q3 FY2010 | 30 Sept 2010 | 361.00M | +24.70% | 100.60M | 260.40M |
| Q2 FY2010 | 30 Jun 2010 | 320.30M | +70.10% | 177.50M | 142.80M |
| Q1 FY2010 | 31 Mar 2010 | 321.20M | +113.56% | 129.30M | 191.90M |
| Q4 FY2009 | 31 Dec 2009 | 334.10M | +47.31% | 90.30M | 243.80M |
| Q3 FY2009 | 30 Sept 2009 | 289.50M | +34.97% | 102.30M | 187.20M |
| Q2 FY2009 | 30 Jun 2009 | 188.30M | -9.51% | 113.90M | 74.40M |
| Q1 FY2009 | 31 Mar 2009 | 150.40M | -20.68% | 123.00M | 27.40M |
| Q4 FY2008 | 31 Dec 2008 | 226.80M | +18.62% | 175.50M | 51.30M |
| Q3 FY2008 | 30 Sept 2008 | 214.50M | +22.08% | 202.80M | 11.70M |
| Q2 FY2008 | 30 Jun 2008 | 208.10M | +26.20% | 141.70M | 66.40M |
| Q1 FY2008 | 31 Mar 2008 | 189.60M | +5.22% | 212.90M | -23.30M |
| Q4 FY2007 | 31 Dec 2007 | 191.20M | +4.60% | 211.70M | -20.50M |
| Q3 FY2007 | 30 Sept 2007 | 175.70M | +16.13% | 211.20M | -35.50M |
| Q2 FY2007 | 30 Jun 2007 | 164.90M | -1.32% | 207.60M | -42.70M |
| Q1 FY2007 | 31 Mar 2007 | 180.20M | -4.66% | 224.50M | -44.30M |
| Q4 FY2006 | 31 Dec 2006 | 182.80M | +2.35% | 235.90M | -53.10M |
| Q3 FY2006 | 30 Sept 2006 | 151.30M | +71.93% | 253.00M | -101.70M |
| Q2 FY2006 | 30 Jun 2006 | 167.10M | +73.88% | 279.60M | -112.50M |
| Q1 FY2006 | 31 Mar 2006 | 189.00M | +160.33% | 289.00M | -100.00M |
| Q4 FY2005 | 31 Dec 2005 | 178.60M | +265.24% | 316.10M | -137.50M |
| Q3 FY2005 | 30 Sept 2005 | 88.00M | +183.87% | 251.50M | -163.50M |
| Q2 FY2005 | 30 Jun 2005 | 96.10M | +140.25% | 269.60M | -173.50M |
| Q1 FY2005 | 31 Mar 2005 | 72.60M | +91.56% | 275.80M | -203.20M |
| Q4 FY2004 | 31 Dec 2004 | 48.90M | -19.97% | 267.10M | -218.20M |
| Q3 FY2004 | 30 Sept 2004 | 31.00M | -19.06% | 269.20M | -238.20M |
| Q2 FY2004 | 30 Jun 2004 | 40.00M | -21.10% | 312.80M | -272.80M |
| Q1 FY2004 | 31 Mar 2004 | 37.90M | +27.18% | 334.50M | -296.60M |
| Q4 FY2003 | 31 Dec 2003 | 61.10M | +78.65% | 255.80M | -194.70M |
| Q3 FY2003 | 30 Sept 2003 | 38.30M | -1.79% | 293.10M | -254.80M |
| Q2 FY2003 | 30 Jun 2003 | 50.70M | +42.82% | 307.30M | -256.60M |
| Q1 FY2003 | 31 Mar 2003 | 29.80M | +6.43% | 276.90M | -247.10M |
| Q4 FY2002 | 31 Dec 2002 | 34.20M | -28.75% | 245.50M | -211.30M |
| Q3 FY2002 | 30 Sept 2002 | 39.00M | +65.96% | 279.90M | -240.90M |
| Q2 FY2002 | 30 Jun 2002 | 35.50M | -42.37% | 297.50M | -262.00M |
| Q1 FY2002 | 31 Mar 2002 | 28.00M | +56.42% | 292.30M | -264.30M |
| Q4 FY2001 | 31 Dec 2001 | 48.00M | +71.43% | 310.90M | -262.90M |
| Q3 FY2001 | 30 Sept 2001 | 23.50M | +78.03% | 339.30M | -315.80M |
| Q2 FY2001 | 30 Jun 2001 | 61.60M | +2,980.00% | 388.20M | -326.60M |
| Q1 FY2001 | 31 Mar 2001 | 17.90M | +198.33% | 414.40M | -396.50M |
| Q4 FY2000 | 31 Dec 2000 | 28.00M | — | 428.00M | -400.00M |
| Q3 FY2000 | 30 Sept 2000 | 13.20M | — | 498.80M | -485.60M |
| Q2 FY2000 | 30 Jun 2000 | 2.00M | — | 531.00M | -529.00M |
| Q1 FY2000 | 31 Mar 2000 | 6.00M | — | 529.00M | -523.00M |
| Q4 FY1999 | 31 Dec 1999 | 0.00 | — | 0.00 | 0.00 |
Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.
See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Total debt,Free cash flow,Stock buybacks,Balance sheet
Common questions about Edwards Lifesciences's cash
Source: Financial Modeling Prep